IMS Health, Abafarma settle Brazilian antitrust data inquiry
IMS Health and Abafarma, an association representing pharmaceutical distributors, have settled an antitrust inquiry in Brazil, agreeing to keep contracts to supply market data free of exclusivity clauses. The regulator didn't impose...To view the full article, register now.
Already a subscriber? Click here to view full article